ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,782Medicare Part D Prescriptions Filled, Including Refills

Rank: 210 out of 780

$597K Total Retail Price of All Prescriptions

Rank: 229 out of 780

560 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 560 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 560 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 10,788 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
LEVOTHYROXINE SODIUM 564 480 1 5
OMEPRAZOLE 560 506 2 3
AMLODIPINE BESYLATE 425 404 3 4
HYDROCODONE-ACETAMINOPHEN 406 324 S3 4 1
LISINOPRIL 364 301 5 6
MELOXICAM 303 272 6 16
FUROSEMIDE 303 274 6 7
ZOLPIDEM TARTRATE 263 220 8 17
CITALOPRAM HBR 257 208 9 23
METFORMIN HCL 247 168 10 8
PRAVASTATIN SODIUM 246 221 11 9
LOSARTAN POTASSIUM 245 227 12 18
TRAMADOL HCL 237 183 13 15
SIMVASTATIN 219 192 14 2
ATENOLOL 207 158 15 21
ATORVASTATIN CALCIUM 194 175 16 12
GABAPENTIN 194 167 16 13
METOPROLOL SUCCINATE 178 141 18 20
POTASSIUM CHLORIDE 177 155 19 11
NEXIUM 167 131 20 22
METOPROLOL TARTRATE 150 122 21 19
TAMSULOSIN HCL 137 129 22 36
CRESTOR 129 111 23 32
PANTOPRAZOLE SODIUM 120 105 24 25
AMLODIPINE BESYLATE-BENAZEPRIL 120 98 24 50
ALLOPURINOL 118 94 26 29
LOSARTAN-HYDROCHLOROTHIAZIDE 116 93 27 33
WARFARIN SODIUM 109 97 28 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 101 29 26
CARVEDILOL 99 90 30 14
ALENDRONATE SODIUM 92 84 31 44
CYMBALTA 91 73 32 51
SYNTHROID 90 73 33 77
HYDROCHLOROTHIAZIDE 89 63 34 10
CEFUROXIME 88 69 35 147
BENAZEPRIL HCL 78 76 36 59
PRAMIPEXOLE DIHYDROCHLORIDE 77 77 37 156
CLOPIDOGREL 75 68 38 34
PREDNISONE 75 69 38 40
TRAZODONE HCL 72 61 40 35
ISOSORBIDE MONONITRATE ER 72 60 40 60
CYCLOBENZAPRINE HCL 71 57 R 42 42
GLIPIZIDE ER 71 71 42 109
IBUPROFEN 69 49 44 93
ESCITALOPRAM OXALATE 69 34 44 61
SINGULAIR 69 45 44 73
LEVOFLOXACIN 60 50 47 76
PLAVIX 60 56 47 45
CELEBREX 58 58 49 89
SERTRALINE HCL 58 28 49 27
KLOR-CON M20 58 37 49 57
AZITHROMYCIN 57 50 52 38
AMITRIPTYLINE HCL 55 37 R 53 48
FLUTICASONE PROPIONATE 55 41 53 41
CIPROFLOXACIN HCL 54 46 55 49
TORSEMIDE 52 49 56 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.